An antibody (or immunoglobulin) is a glycoprotein produced by the immune system in response to a ‘foreign ... They are classified into primary and secondary based on their binding capability ...

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO ...

The prespecified primary immunogenicity objectives were to show neutralizing antibody responses that were noninferior to 50-μg mRNA-1273 (on the basis of geometric mean titer ratio and difference ...

HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial ... and 12 weeks after vaccination. The primary outcome was fold rise in antibody titers from ...

The new results are the latest from Wilson's team tracking the antibody response to the COVID-19 vaccines over time. The researchers previously found that after the primary vaccination series the ...

Researchers led by Imperial have unveiled primary trial ... that an immune response can be harnessed to control HIV, ...

They found that upon primary immunization, participants with pre-existing immunity (those who had previously been infected with the virus) mounted higher antibody responses faster and achieved ...